While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

OpenAI claims its new reasoning model has produced an original mathematical proof disproving a famous unsolved conjecture in geometry, which was first posed by Paul Erdős in 1946. If this sounds ...

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

One idle evening last October, Mehtaab Sawhney took up an old pastime. He began perusing the website erdosproblems.com, an updated record of the 1,179 conjectures left behind by the eccentric and ...

What are the most pressing global crises in 2026? Each year, the International Rescue Committee’s (IRC) Emergency Watchlist identifies the countries at greatest risk of new or worsening humanitarian ...

Five years ago, mathematicians Dawei Chen and Quentin Gendron were trying to untangle a difficult area of algebraic geometry involving differentials, elements of calculus used to measure distance ...

Microsoft’s MSFT-2.08%decrease; down pointing triangle Copilot chatbot has become central to its artificial-intelligence strategy as the company’s close partnership with OpenAI diminishes. But the ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

Recursion Pharmaceuticals utilizes a proprietary operating system (OS) and an AI-powered algorithm that continuously runs virtual experiments, testing compounds against a library of human genes to ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...